Aetna policy
0921-Daunorubicin-Cytarabine Liposome (Vyxeos)
0921-Daunorubicin-Cytarabine Liposome (Vyxeos) is a public Aetna policy (policy 0921). It lists 4 CPT or HCPCS codes. Not a coverage decision; the payer's own document governs.
Check eligibility for free
No account required. Sign a BAA to see plan details, coordination of benefits and more
- Payer
- Aetna
- Policy number
- 0921
- Line of business
- Commercial
- Source
- www.aetna.com
Codes in this policy
The CPT and HCPCS codes the policy names. A policy can name a code it excludes. Open official prior authorization lists to check the member’s product.
| Code | Other Aetna policies |
|---|---|
| 96413 | Policies naming 96413 |
| 96417 | Policies naming 96417 |
| J9100 | Policies naming J9100 |
| J9153 | Policies naming J9153 |